These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3145960)

  • 1. [A case of combined lysinuric protein intolerance and hypoactivity of argininosuccinate synthetase (citrullinemia)].
    Shioya K; Yamamura Y; Kurihara T; Matsukura S
    Nihon Naika Gakkai Zasshi; 1988 May; 77(5):667-73. PubMed ID: 3145960
    [No Abstract]   [Full Text] [Related]  

  • 2. Lysinuric protein intolerance presenting deficiency of argininosuccinate synthetase.
    Ono N; Kishida K; Tokumoto K; Watanabe M; Shimada Y; Yoshinaga J; Fujii M
    Intern Med; 1992 Jan; 31(1):55-9. PubMed ID: 1568044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A variant form of citrullinemia.
    Matsuda I; Anakura M; Arashima S; Saito Y; Oka Y
    J Pediatr; 1976 May; 88(5):824-6. PubMed ID: 1271146
    [No Abstract]   [Full Text] [Related]  

  • 4. Citrullinemia presenting as uncontrollable epilepsy.
    Origuchi Y; Ushijima T; Sakaguchi M; Akaboshi I; Matsuda I
    Brain Dev; 1984; 6(3):328-31. PubMed ID: 6486381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocitrullinuria and homoargininuria in lysinuric protein intolerance.
    Kato T; Sano M; Mizutani N
    J Inherit Metab Dis; 1989; 12(2):157-61. PubMed ID: 2474087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysinuric protein intolerance. Urinary amino acid excretion at 2 and 9 days of age.
    Candito M; Vianey-Saban C; Ferraci JP; Bébin B; Chazalette JP; Sebag F; Mathieu M; Chambon P
    J Inherit Metab Dis; 1994; 17(2):252-3. PubMed ID: 7967486
    [No Abstract]   [Full Text] [Related]  

  • 7. An adult-onset case of argininosuccinate synthetase deficiency presenting with atypical citrullinemia.
    Osafune K; Ichikawa K; Yasui T; Sekikawa A; Takeoka H; Kanatsu K; Kohigashi K; Koshiyama H
    Intern Med; 1999 Jul; 38(7):590-6. PubMed ID: 10435367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Citrullinemia].
    Vidailhet M; Levin B; Dautrevaux M; Paysant P; Gelot S; Badonnel Y; Pierson M; Neimann N
    Arch Fr Pediatr; 1971 May; 28(5):521-32. PubMed ID: 5561754
    [No Abstract]   [Full Text] [Related]  

  • 9. Generation of a mouse model for citrullinemia by targeted disruption of the argininosuccinate synthetase gene.
    Patejunas G; Bradley A; Beaudet AL; O'Brien WE
    Somat Cell Mol Genet; 1994 Jan; 20(1):55-60. PubMed ID: 8197477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protein intolerance with lysinuria. Value of orotic aciduria in adjusting treatment with citrulline].
    de Parscau L; Vianey-Liaud C; Hermier M; Divry P; Guibaud P
    Arch Fr Pediatr; 1988 Dec; 45(10):809-12. PubMed ID: 3149174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in argininosuccinate synthetase activity in amniotic fluid cell cultures: implications for prenatal diagnosis of citrullinemia.
    Jacoby LB; Shih VE; Struckmeyer C; Niermeijer MF; Boué J
    Clin Chim Acta; 1981 Oct; 116(1):1-7. PubMed ID: 7318168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysinuric protein intolerance presenting as childhood osteoporosis. Clinical and skeletal response to citrulline therapy.
    Carpenter TO; Levy HL; Holtrop ME; Shih VE; Anast CS
    N Engl J Med; 1985 Jan; 312(5):290-4. PubMed ID: 3917550
    [No Abstract]   [Full Text] [Related]  

  • 13. Lysinuric protein intolerance: a rare cause of childhood osteoporosis.
    Nutr Rev; 1986 Mar; 44(3):110-3. PubMed ID: 3083306
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased urinary excretion of argininosuccinate in type II citrullinemia.
    Saheki T; Kobayashi K; Inoue I; Matuo S; Hagihara S; Noda T
    Clin Chim Acta; 1987 Dec; 170(2-3):297-304. PubMed ID: 3436063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of transient neonatal citrullinemia.
    Ohtake A; Takayanagi M; Ogura N; Nakajima H
    Eur J Pediatr; 1983 Oct; 141(1):60-1. PubMed ID: 6641770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal diagnosis of citrullinemia: elevated levels of citrulline in the amniotic fluid in the three affected pregnancies.
    Kleijer WJ; Blom W; Huijmans JG; Mooyman MC; Berger R; Niermeijer MF
    Prenat Diagn; 1984; 4(2):113-8. PubMed ID: 6739433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citrullinemia: early diagnosis & successful management of an otherwise lethal disorder.
    Balsekar MV; Ambani LM; Bhatia RS; Shah SB; Apte BN
    Indian Pediatr; 1989 Jun; 26(6):589-92. PubMed ID: 2583813
    [No Abstract]   [Full Text] [Related]  

  • 18. Prospective management of a child with neonatal citrullinemia.
    Melnyk AR; Matalon R; Henry BW; Zeller WP; Lange C
    J Pediatr; 1993 Jan; 122(1):96-8. PubMed ID: 8419623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of citrullinemia with abnormal messenger RNA for argininosuccinate synthetase.
    Nukada O; Uchiyama C; Ubuka S; Yoda T; Kobayashi K; Ichiki H; Saheki T
    Acta Paediatr Jpn; 1991 Oct; 33(5):672-7. PubMed ID: 1799125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving a Rare Metabolic Disorder Through Kidney Transplantation: A Case Report of a Patient With Lysinuric Protein Intolerance.
    IJzermans T; van der Meijden W; Hoeks M; Huigen M; Rennings A; Nijenhuis T
    Am J Kidney Dis; 2023 Apr; 81(4):493-496. PubMed ID: 36223829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.